AKTX vs AAPL: Which Stock is Better?
Side-by-side comparison of Akari Therapeutics Plc and Apple Inc in 2026
AKTX
Akari Therapeutics Plc
$0.16
AAPL
Apple Inc
$249.79
Key Metrics Comparison
| Metric | AKTX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $16.96M | N/A | AKTX |
| P/E Ratio | N/A | 32.14 | AAPL |
| EPS (TTM) | $N/A | $7.91 | AAPL |
| Revenue Growth | 0.0% | 0.2% | AAPL |
| Gross Margin | 0.0% | 47.3% | AAPL |
Analyze AKTX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AKTX or AAPL a better investment?
Comparing AKTX and AAPL: Akari Therapeutics Plc has a market cap of $16.96M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AKTX and AAPL?
AKTX (Akari Therapeutics Plc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AKTX or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AKTX or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.0% for AKTX.
Which company is more profitable: AKTX or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 0.0% for AKTX.
Which is the larger company: AKTX or AAPL?
Akari Therapeutics Plc (AKTX) is larger with a market cap of $16.96M compared to N/A for AAPL.
Should I buy AKTX or AAPL in 2026?
Both AKTX and AAPL have investment merit. AKTX trades at $0.16 while AAPL trades at $249.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AKTX and AAPL stock?
Key differences: Market Cap ($16.96M vs N/A), P/E Ratio (N/A vs 32.1x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 47.3%).